Ghrelin in gastrointestinal diseases and disorders: A possible role in the pathophysiology and clinical implications (review)

International Journal of Molecular Medicine

Volumn 24, Issue 6, 2009, Pages 727-732

  El Salhy, Magdy ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Disease; Disorder; Gastrointestinal tract; Ghrelin; Oxyntic mucosa

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE;

ANTIINFLAMMATORY ACTIVITY; BARIATRIC SURGERY; BODY WEIGHT DISORDER; CELIAC DISEASE; CLINICAL TRIAL; COLITIS; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; ENDOTOXEMIA; ENERGY METABOLISM; ENTERITIS; FEEDING BEHAVIOR; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GLUTEN FREE DIET; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IDIOPATHIC DISEASE; IMMUNOMODULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE MOTILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SHOCK; STOMACH CANCER; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; STREPTOZOCIN DIABETES; ULCERATIVE COLITIS;

BARIATRIC SURGERY; DIABETES MELLITUS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; GHRELIN; HUMANS; STOMACH NEOPLASMS;

EID: 70350778323     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000285     Document Type: Review

References (64)

1. Kojima M, Hosoda H, Date J, Nakazato M, Matsuo H and Kangawa K: Ghrelin is growth-hormone-releasing acetylated peptide from stomach. Nature 402: 656-660, 1999.
2. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K and Nakazato M: Ghrelin, a novel growth hormone-releasing acetylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141: 4255-4261, 2000.
3. Erdmann J, Töpsch R, Lippl F, Gussmann P and Schusdziarra V: Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin and glucose. J Clin Endocrinol Metab 89: 3048-3054, 2004.
4. Hosoda H and Kangawa K: The autonomic nervous system regulates gastric gherlin secretion in rats. Regul Pep 146: 12-18, 2008.
5. Takeshita E, Matsura B, Dong M, Miller LJ, Matsui H and Onji M: Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol 41: 223-230, 2006.
6. Hataya Y, Akamizu T, Takaya K, Ariyasu N, Sajjo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K and Nakao K A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86: 4552-4555, 2001.
7. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo LO, Ghatei MA and Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992, 2001.
8. Hosoda H, Kojima M and Kangawa K: Ghrelin and the regulation of food intake and energy balance. Mol Interv 8: 494-503, 2002.
9. Gonzalez-Rey E, Chorny A and Delgado M: Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130: 1707-1720, 2006.
10. Waseem T, Duxbury M, Ito H, Ashley SW and Robinson MK: Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signalling pathway. Surgery 143: 334-342, 2008.
11. Dornonville de la Cour C, Lindström E, Norén P and Håkanson R: Ghrelin stimulates gastric emptying but without effect on acid secretion and gastric endocrine cells. Regul Pep 120: 23-32, 2004.
12. Levin F, Edholm T, Schmidt PT, Grybäck P, Jacobsson H, Dergerblad M, Höybye C, Holst JJ, Hellström PM and Näslund E: Ghrelin stimulates gastric emptying and hunger in normal weight humans. J Clin Endocrinol Metab 91: 3279-3280, 2006.
13. Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J and Peeters T: Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 55: 327-333, 2006.
14. Ariga H, Tsukamoto K, Chen C, Mantyh C, Pappas TN and Takahashi T: Endogenous acyl gherlin is involved in mediating spontaneous phase III-like contractions in the rat stomach. Neurogastroenterol Motil 19: 675-680, 2007.
15. Ariga H, Nakade Y, Tsukamoto K, Imai K, Mantyh C, Pappas TN and Takahashi T: Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. Regul Pep 146: 112-116, 2008.
16. Tümer C, Oflazoglu HD, Obay BD, Kelle M and Tasdemir E: Effects of ghrelin on gastric myoelectrical activity and gastric emptying in rats. Regul Pep 146: 26-32, 2008.
17. Fukuda H, Mizuta Y, Isomoto H, Takeshima F, Ohnita K, Ohba K, Omagari K, Taniyama K and Kohno S: Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 39: 1209-1211, 2004.
18. Edholm T, Levin F, Hellerström PM and Schmidt PT: Ghrelin stimulates motility in the small intestine of rats. Regul Pep 121: 25-30, 2004.
19. Tabbe JJ, Mronga S, Tebbe CG, Oertmann E, Arnold R and Schäfer K: Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol 17: 570-576, 2005.
20. Ohno T, Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T and Kuwano H: Ghrelin does not stimulate gastrointestinal motility and gastric emptying: an experimental study of conscious dogs. Neurogastroenterol Motil 18: 129-135, 2006.
21. Karmiris K, Koutroubakis I, Xidakis C, Polychronaki M, Voudouri T and Kouroumalis EA: Circulating levels of leptin, adiponectin, resistin, and gherlin in inflammatory bowel disease. Inflamm Bowel Dis 12: 100-105, 2006.
22. Ripollés PB, Nazih H, Bourreille A, Segain JP, Huvelin JM, Galmiche JP and Bard JM: Altered lipid, apolipoprotein and lipoprotein profiles in inflammatory bowel diseases: consequences on the cholestrol efflux capacity of serum using Fu5AH cell system. Metabol 55: 980-988, 2006.
23. Ates Y, Degertekin B, Edril A, Yaman H and Dagalp K: Serum gherlin levels in inflammatory bowel disease with relation to disease activity and nutrition status. Dig Dis Sci 53: 2215-2221 2008.
24. Selimoglu MA, Altinkaynak S, Ertekin V and Akcay F: Serum ghrelin levels in children with celiac disease. J Clin Gastroenterol 40: 191-194, 2006.
25. Corazza GR, Di Sario A, Sacco G, Zoli G, Treggiari EA and Brusco G: Subclinical coeliac disease: an anthropometric assessment. J Intern Med 236: 183-187, 1994.
26. Capristo E, Farnetti S, Mingrone G, Certo M, Greco AV, Addolorato G and Gasbarrini G: Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand J Gastroenterol 40: 430-436, 2005.
27. Peracchi M, Conte D, Terrani C, Pizzinelli S, Gebbia C, Cappiello V, Spada A and Bardella MT: Circulating ghrelin levels in celiac patients. Am J Gastroenterol 98: 2474-2478, 2003.
28. Lanzini A, Magni P, Petroni ML, Motta M, Lanzarotto F, Villanacci V, Amato M, Mora A, Bertolazzi S, Benini F and Ricci C: Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment Pharmacol Ther 23: 907-913, 2006.
29. Capristo E, Addolorato G, Mingrone G, De Gaetano A, Greco AV and Tataranni PA: Changes in body composition, substrate oxidation, and resting metabolic rate in adult coeliac disease patients after 1-year gluten-free diet treatment. Am J Clin Nutr 72: 76-78, 2000.
30. Checchi S, Montanaro A, Pasqui L, Ciuoli C, Cevenini G, Sestini F, Fioravanti C and Pacini F: Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 92: 4346-4351, 2007.
31. Alnoso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martinz-Cácerees EM and Sanmarti A: Plasma ghrelin in type 1 diabetic patients with autoimmune atrophic gastritis. Eur J Endocrinol 157: 763-769, 2007.
32. Campana D, Nori F, Pagotto U, De Iasio R, Morselli-Labate AM, Pasquali Corinaldesi R and Tomassetti P: Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. Clin Endocrinol 67: 761-766, 2007.
33. Vila G, Maier C, Riedl M, Nowotny P, Ludvik B, Luger A and Coldi M: Bacterial edotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 92: 3930-3934, 2007.
34. Madison LD, Scarlett JM, Levasseur P, Zhu X, Newcomb K, Batra A, Bowe D and Marks DL: Prostacyclin signalling regulates circulating ghrelin during acute inflammation. J Endocrinol 196: 263-273, 2008.
35. Fetissov SO, Hamze Sinno M, Coëffier M, Bole-Feysot C, Ducrotté P, Hökfelt T and Déchelotte P: Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 24: 348-359, 2008.
36. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Sato K, Ishino Y and Sugano K: Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 90: 10-16, 2005.
37. Shiotani A, Mivanashi T, Uedo N and Iishi H: Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 10: 373-378, 2005.
38. Osawa H, Kita H, Ohnishi H, Nakazato M, Date Y, Bowlus CL, Ishino Y, Watanabe E, Shiiya T, Ueno H, Hoshino H, Satoh K and Sugano K: Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J Gastroenterol 41: 954-961, 2006.
39. Liew PL, Lee WJ, Lee YC and Chen WY: Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients. Obes Surg 16: 612-619, 2006.
40. Cindourk M, Yetkin I, Deger SM, Kareakan T, Kan E and Unal S: Influence of H. pylori on plasma ghrelin in patients without atrophic gastritis. World J Gastroenterol 13: 1595-1598, 2007.
41. Nishizawa T, Suzuki H, Nomoto Y, Hosoda H, Mori M, Oharat T, Morishita K, Kangawa K and Hibi T: Enhanced plasma ghrelin in patients with functional dysplasia. AP &TSS 2: 104-110, 2006.
42. Takamori K, Mizuta Y, Takeshima F, Akazawa Y, Isomoto H, Ohnita K, Ohba K, Omagari K, Shikuwa S and Kohno S: Relation among plasma ghrelin level, gastric emptying and psychologic condition in patients with functional dyspepsia. J Clin Gastroenterol 41: 477-483, 2007.
43. El-Salhy M, Lillebø E, Reinemo A and Salmelid L: Ghrelin in patients with irritable bowel syndrome. Int J Mol Med 23: 703-707, 2009.
44. Rauma J, Spångéus A and El-Salhy M: Ghrelin cell density in the gastrointestinal tracts of animal models of type 1 and type 2 diabetes. Histol Histopathol 21: 1-5, 2006.
45. Masaoka T, Suzuki H, Hosoda H, Ota T, Minegishi Y, Nagata H, Kangawa K and Ishii H: Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett 541: 64-68, 2003.
46. El-Salhy M and Rauma J: Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with diabetes type 1. Mol Med Rep 2: 893-896, 2009.
47. Irako T, Akamizu T, Hosoda H, Iwakura H, Ariyasu H, Tojo K, Tajima N and Kangawa K: Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. Diabetologia 49: 1264-1273, 2006.
48. Binn M, Albert C, Gougeon A, Maereki H, Coulie B, Lemoyne M, Rabasa Lhoret R, Tomasetto C and Poitras P: Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 27: 1603-1606, 2006.
49. Murray CDR, Martin NM, Patterson M, Taylor SA, Ghatei MA, Kamm MA, Johnston C, Bloom SR and Emmanuel AV: Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled,crossover study. Gut 54: 1693-1698, 2005
50. An JY, Choi MG, Noh JH, Sohn TS, Jin DK and Kim S: Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res 143: 344-349, 2007.
51. D'Onghia V, Leoncini R, Carli R, Santoro A, Giglioni S, Sorbellini E, Marzocca G, Bernini A, Campagna S, Marinello E, and Vannoni D: Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 61: 137-141, 2007.
52. Huang Q, Fan YZ, Ge BJ, Zhu Q and Tu ZY: Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci 52: 803-809, 2007.
53. Tsolakis AV, Stridsberg M, Grimelius L, Portela-Gomes GM, Falkmer SE, Waldum HI and Janson ET: Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration. J Clin Gastroenterol 42: 381-388, 2008.
54. Raffel A, Krausch M, Cupisti K, Gerharz CD, Eisenberger CF and Knoefel WT: Ghrelin expression in neuroendocrine tumours of the gastrointestinal tract with multiple endocrine neoplasia type 1. Horm Metab Res 37: 653-655, 2005.
55. Chan JL, Mun EC, Stoyneva V, Mantozros CS and Goldfine AB: Peptide YY levels are elevated after gastric bypass surgery. Obesity 14: 194-198, 2006.
56. Moringo R, Casamitjana R, Moizé V, Lacy AM, Delgado S, Gomis R and Vidal J: Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res 12: 1108-1116, 2004.
57. Whitson BA, Leslie DB, Kellogg TA, Buchwald H, Billington CJ and Ikramuddin S: Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res 141: 31-39, 2007.
58. Rodieux F, Giusti V, Dálessio DA, Suter M and Tappy L: Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity 16: 298-305, 2008.
59. Uzzan B, Catheline JM, Lagoree C, Airnei G, Bon C, Cohen R, Perret GY, Aparicio T and Benamouzig R: Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients. Obes Surg 9: 1159-1164, 2007.
60. Schindler K, Prager G, Ballaban T, Kretschmer S, Reiner R, Buranyi B, Mair C, Luger A and Ludvik B: Impact of laparpscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34: 549-454, 2004.
61. Adami GF, Cordera R, Marinari G, Lamerini G, Andraghetti G and Scopinaro N: Plasma Ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg 13: 889-892, 2003.
62. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbaur FX, Zacherl J, Wenzl E, Schindler K, Lunger A, Ludvik B and Prager G: Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15, 1501-1502, 2005.
63. Santoro S, Milleo FQ, Malzoni CE, Klajneer S, Borges PC, Santo MA, Campos FG and Artoni RF: Enterohormonal changes after digestive adaptation: five-year results of surgical proposal to treat obesity and associated diseases. Obes Surg 18: 17-26, 2008.
64. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J and Peeters T: Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 22: 847-853, 2005.